Cumbo Alexander Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$9.55M

Insider Activity of Cumbo Alexander

According to the SEC Form 4 filings, Cumbo Alexander, being in a position of

  1. President and CEO at Solid Biosciences Inc.,
    оver the last 12 months, has bought 0 shares, and sold 156623 shares for $983,857,
    over all time since 2023-12-04, has bought 0 shares, and sold 190859 shares for $1.12M.

Biography of Cumbo Alexander

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$983,8574100

Comparison of Insiders on Amount of Buys and Sells

2026-02-18SaleSolid Biosciences Inc.
SLDB
President and CEO
16,644
0.021%
$5.82$96,923+29.73%
2026-02-04SaleSolid Biosciences Inc.
SLDB
President and CEO
48,913
0.062%
$6.44$315,093+14.72%
2026-02-02SaleSolid Biosciences Inc.
SLDB
President and CEO
80,258
0.1031%
$6.44$516,613+16.1%
2025-12-03SaleSolid Biosciences Inc.
SLDB
President and CEO
10,808
0.0137%
$5.11$55,229+37.76%
2025-02-14SaleSolid Biosciences Inc.
SLDB
President and CEO
11,365
0.0286%
$3.96$45,005+33.75%
2024-12-03SaleSolid Biosciences Inc.
SLDB
President and CEO
11,114
0.0299%
$5.60$62,236-6.47%
2023-12-04SaleSolid Biosciences Inc.
SLDB
President and CEO
11,757
0.0459%
$2.77$32,516+128.2%
2019-12-13SaleSarepta Therapeutics, Inc.
SRPT
EVP, Chief Commercial Officer
42,000
0.0522%
$125.50$5.27M+4.3%
2019-02-01SaleSarepta Therapeutics, Inc.
SRPT
SVP, Chief Commercial Officer
15,000
0.021%
$140.00$2.1M-13.46%
2018-07-09SaleSarepta Therapeutics, Inc.
SRPT
SVP, Chief Commercial Officer
23,838
0.0197%
$75.49$1.8M-8.97%
2017-07-20SaleSarepta Therapeutics, Inc.
SRPT
SVP, Chief Commercial Officer
5,918
0.0096%
$41.00$242,638+46.25%
Total: 11
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.